陈红风基于肝肾同源论治乳腺癌芳香化酶抑制剂相关肌肉骨骼综合征经验介绍

Introduction to CHEN Hongfeng's Experience in Treating Aromatase Inhibitor-Related Musculoskeletal Syndrome of Breast Cancer Based on Liver-Kidney Homology

摘要:

介绍陈红风教授基于肝肾同源论治乳腺癌芳香化酶抑制剂相关肌肉骨骼综合征的临床经验。陈红风教授认为，乳腺癌芳香化酶抑制剂相关肌肉骨骼综合征属中医乳岩、骨痹范畴。陈红风教授基于“肝肾同为女子之先天”的理论，认为肝肾精血互生，藏泄互用，肝肾不足、虚损失调为本病的主要病机。故临证强调子母相生的组方原则，从肝肾通调阴阳，滋水涵木继而正气得固，创拟益肾调肝方，随症加减治疗乳腺癌芳香化酶抑制剂相关肌肉骨骼综合征。

Abstract:

Abstract： This paper introduces the clinical experience of Professor CHEN Hongfeng in treating aromatase inhibitor-related musculoskeletal syndrome （AIMSS） of breast cancer based on liver-kidney homology. Professor CHEN Hongfeng holds that AIMSS of breast cancer falls into the categories of Ruyan （breast cancer） and Gubi （bone impediment） in traditional Chinese medicine （TCM）. Based on the theory that liver and kidney are both the congenital foundation for women，Professor CHEN believes that essence and blood of liver and kidney generate each other，with storing and discharging mutually regulating； liver-kidney insufficiency and deficiency with dysfunction are the main pathogenesis of this disease. Therefore，in clinical practice，she emphasizes the formulation principle of mother-organ generating child-organ， regulates yin and yang through liver and kidney， nourishes water to enrich wood， thereby consolidating healthy qi. She has formulated Yishen Tiaogan Prescription and treats AIMSS of breast cancer with modified application according to symptoms.